Kampanjeplan Orchestra BioMed Holdings, Inc.
Avansert tidsplan
Enkel graf
Om selskapet Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. flere detaljerIPO date | 2020-08-04 |
---|---|
ISIN | US68572M1062 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://orchestrabiomed.com |
Цена ао | 3.84 |
Prisendring per dag: | +6.25% (3.84) |
---|---|
Prisendring per uke: | -3.55% (4.23) |
Prisendring per måned: | -23.45% (5.33) |
Prisendring over 3 måneder: | -22.43% (5.26) |
Prisendring over seks måneder: | -17.07% (4.92) |
Prisendring per år: | -23.31% (5.32) |
Prisendring over 3 år: | -58.75% (9.89) |
Prisendring over 5 år: | 0% (4.08) |
Prisendring over 10 år: | 0% (4.08) |
Prisendring siden begynnelsen av året: | -17.07% (4.92) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
RTW Investments LP | 5620640 | 15.71 |
Perceptive Advisors LLC | 2432089 | 6.8 |
Blackrock Inc. | 1468768 | 4.11 |
Vanguard Group Inc | 1227282 | 3.43 |
Price (T.Rowe) Associates Inc | 622608 | 1.74 |
Geode Capital Management, LLC | 425749 | 1.19 |
State Street Corporation | 285910 | 0.8 |
Boxer Capital, LLC | 238193 | 0.67 |
Charles Schwab Investment Management, Inc. | 175545 | 0.49 |
Northern Trust Corporation | 142879 | 0.4 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.02967 | 17.09 | 1.54048 |
Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
![]() |
0.00387 | 38.04 | 0.6026 |
![]() |
0.00339 | 17.47 | 1.51433 |
![]() |
0.00248 | 89.82 | 1.47873 |
Avantis U.S Small Cap Equity ETF | 0.00162 | 27.77 | 1.68271 |
ProShares Hedge Replication ETF | 0.00069 | 5.92 | 1.47892 |
![]() |
0.00032 | 24.86 | 1.43354 |
Vanguard Russell 2000 Growth ETF | 0 | 23.05 | 0.60264 |
Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
0.00000 | 29.3 | 1.32 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. David P. Hochman | Founder, Chairman of the Board of Directors & CEO | 942k | 1975 (50 år) |
Mr. Darren R. Sherman | Founder, President, COO & Director | 787k | 1971 (54 år) |
Mr. Andrew Lawrence Taylor M.B.A. | Chief Financial Officer | 500.02k | 1971 (54 år) |
Mr. William Reed Little | Executive Vice President of Corporate Development & Strategy | N/A | 1971 (54 år) |
Dr. Yuval Hay Mika D.Sc, Ph.D. | GM & CTO of Bioelectronic Therapies | N/A | 1959 (66 år) |
Dr. George Papandreou Ph.D. | GM & Senior VP of Focal Therapies | N/A | 1965 (60 år) |
Dr. Hans-Peter Stoll M.D., Ph.D. | Chief Clinical Officer | N/A | |
Dr. Avraham Matityahu Fischer M.D. | Senior Vice President of Medical Affairs & Innovation | N/A | 1956 (69 år) |
Mr. Bob Laughner | Senior Vice President of Regulatory & Quality | N/A | |
Mr. Juan Lorenzo | Senior Vice President of Product Development | N/A |
Adresse: United States, New Hope. PA, 150 Union Square Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: https://orchestrabiomed.com
Nettsted: https://orchestrabiomed.com